Yew Bio-Pharm Group, Inc.
company.status.inactiveCIK 1548240fmd_02SAZZM6X7WP8VNV467PG31283Agriculture, Forestry and Fishing · Agricultural Production-CropsTemplate: Standard
Coverage: Jan 01, 2011 to Sep 30, 2021, 42 periods
Latest annual · FY2020
Millions- Total revenues
- 27
- Gross profit
- 4
- Operating income
- 3
- Net income
- 1
- Free cash flow
- 17
Latest quarter · Q3 FY2021
Millions- Total revenues
- 0
- Gross profit
- (1)
- Operating income
- (2)
- Net income
- (2)
- Free cash flow
- 6
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2017 to FY2020
- -12.3%
- Revenue, 5 yearsFY2015 to FY2020
- -1.6%
- Net income, 5 yearsFY2015 to FY2020
- -22.6%
Yew Bio-Pharm Group, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2020 | FY2019 | Change | Source |
|---|---|---|---|---|
| Revenue | $27.3 million | $27.9 million | -2.1% | 10-K 2021-03-30 · proof |
| Gross profit | $3.5 million | $774,131 | +355.6% | 10-K 2021-03-30 · proof |
| Operating income | $2.6 million | $1 million | +153.9% | 10-K 2021-03-30 · proof |
| Net income | $1.5 million | $985,506 | +48.6% | 10-K 2021-03-30 · proof |
| Cash from operating activities | $17.3 million | $12 million | +45.1% | 10-K 2021-03-30 · proof |
| Free cash flow | $17.3 million | $11.9 million | +44.9% | 10-K 2021-03-30 · proof |
| Total assets | $58.4 million | $54.2 million | +7.8% | 10-K 2021-03-30 · proof |
| Total liabilities | $13 million | $12.8 million | +1.2% | 10-K 2021-03-30 · proof |
| Cash and cash equivalents | $563,792 | $742,294 | -24% | 10-K 2021-03-30 · proof |
- What was Yew Bio-Pharm Group, Inc.'s revenue in fiscal 2020?
- Yew Bio-Pharm Group, Inc. reported revenue of $27.3 million for fiscal 2020 (the year ended Dec 31, 2020), against $27.9 million the year before (-2.1%). Source: the 10-K filed with the SEC on Mar 30, 2021. SEC
- What was Yew Bio-Pharm Group, Inc.'s gross profit in fiscal 2020?
- Yew Bio-Pharm Group, Inc. reported gross profit of $3.5 million for fiscal 2020 (the year ended Dec 31, 2020), against $774,131 the year before (+355.6%). Source: the 10-K filed with the SEC on Mar 30, 2021. SEC
- What was Yew Bio-Pharm Group, Inc.'s operating income in fiscal 2020?
- Yew Bio-Pharm Group, Inc. reported operating income of $2.6 million for fiscal 2020 (the year ended Dec 31, 2020), against $1 million the year before (+153.9%). Source: the 10-K filed with the SEC on Mar 30, 2021. SEC
- What was Yew Bio-Pharm Group, Inc.'s net income in fiscal 2020?
- Yew Bio-Pharm Group, Inc. reported net income of $1.5 million for fiscal 2020 (the year ended Dec 31, 2020), against $985,506 the year before (+48.6%). Source: the 10-K filed with the SEC on Mar 30, 2021. SEC
- What was Yew Bio-Pharm Group, Inc.'s cash from operating activities in fiscal 2020?
- Yew Bio-Pharm Group, Inc. reported cash from operating activities of $17.3 million for fiscal 2020 (the year ended Dec 31, 2020), against $12 million the year before (+45.1%). Source: the 10-K filed with the SEC on Mar 30, 2021. SEC
- What was Yew Bio-Pharm Group, Inc.'s free cash flow in fiscal 2020?
- Yew Bio-Pharm Group, Inc. reported free cash flow of $17.3 million for fiscal 2020 (the year ended Dec 31, 2020), against $11.9 million the year before (+44.9%). Source: the 10-K filed with the SEC on Mar 30, 2021. SEC
- What are Yew Bio-Pharm Group, Inc.'s total assets?
- As of Dec 31, 2020, Yew Bio-Pharm Group, Inc. reported total assets of $58.4 million, against $54.2 million a year earlier (+7.8%). Source: the 10-K filed with the SEC on Mar 30, 2021. SEC
- What are Yew Bio-Pharm Group, Inc.'s total liabilities?
- As of Dec 31, 2020, Yew Bio-Pharm Group, Inc. reported total liabilities of $13 million, against $12.8 million a year earlier (+1.2%). Source: the 10-K filed with the SEC on Mar 30, 2021. SEC
- What are Yew Bio-Pharm Group, Inc.'s cash and cash equivalents?
- As of Dec 31, 2020, Yew Bio-Pharm Group, Inc. reported cash and cash equivalents of $563,792, against $742,294 a year earlier (-24%). Source: the 10-K filed with the SEC on Mar 30, 2021. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1548240&period_type=annual&limit=5"Information only, not investment advice.